Stay updated on Biogen Press Releases

Sign up to get notified when there's something new on the Biogen Press Releases page.
Latest website image capture
Clouds background image

Latest updates to the Biogen Press Releases page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    The latest releases now include Biogen’s third-quarter 2026 results and plans to present Alzheimer’s disease portfolio data at CTAD 2026. Older announcements about Dravet syndrome conference presentations and a Canadian LEQEMBI reimbursement recommendation have been removed from the listing.
    Difference
    4%
    Check dated 2026-10-31T13:09:55.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    The news list adds an October 19, 2026 announcement that Biogen will present nephrology data, including long-term Phase 3 EMPAVELI results, at ASN Kidney Week. An August 27, 2026 announcement about Biogen participating in the Morgan Stanley healthcare conference is no longer listed.
    Difference
    4%
    Check dated 2026-10-24T14:41:35.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    The news releases list adds Biogen’s preliminary third-quarter 2026 acquired in-process research and development charges announcement and removes its notice of participation in the Wells Fargo 21st Annual Healthcare Conference.
    Difference
    4%
    Check dated 2026-10-17T14:31:11.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    The news list adds Biogen’s report of 52-week Phase 2 data on litifilimab for cutaneous lupus and removes the earlier announcement that the LEQEMBI IQLIK autoinjector became available in the U.S.
    Difference
    4%
    Check dated 2026-10-03T14:45:52.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    Three new press releases were added to the News Releases list: Phase 3 EMPAVELI data, Biogen's Q3 2026 financial results, and LEQEMBI Pen approval in Japan. Three older items were removed to refresh the listing (RayThera acquisition, Q2 2026 results, and the Chief Legal Officer appointment).
    Difference
    4%
    Check dated 2026-09-19T21:47:19.000Z thumbnail image
  7. Check
    69 days ago
    Change Detected
    Summary
    New items appear on the Biogen News page for September 3 and September 1, 2026, including data presentations on Zorevunersen and regulatory updates for LEQEMBI, as well as a positive reimbursement recommendation in Canada; older July 2026 items have been removed from the list.
    Difference
    4%
    Check dated 2026-09-05T19:28:35.000Z thumbnail image

Stay in the know with updates to Biogen Press Releases

Enter your email address, and we'll notify you when there's something new on the Biogen Press Releases page.